Juvenile psoriasis and its clinical management: a European expert group consensus
M. Stahle, Nilgun Atakan, Wolf-Henning Boehncke, Sergio Chimenti, E. Dauden, Alberto Giannetti, Peter Hoeger, Pascal Joly, Andreas Katsambas, Knud Kragballe, Jo Lambert, Jean-Paul Ortonnehttp://academic.research.microsoft.com/io.ashx?type=5&id=33940891&selfId1=0&selfId2=0&maxNumber=12&query=
BACKGROUND: Psoriasis, an inflammatory disorder of the skin, can significantly impact on a patient's quality of life, affecting their daily activities and families. The onset of psoriasis in childhood is quite common; however, the treatment of moderate-to-severe disease in this population is challenging, with a paucity of data reported and few licensed agents available. METHODS: A Delphi survey was conducted among a panel of European expert dermatologists and physicians with a particular interest in pediatric inflammatory disorders. The survey covered the aspects of psoriasis types, psoriatic arthritis, diagnosis and treatment options in childhood. RESULTS: A series of consensus opinions were reached, detailing the current practice in Europe for the diagnosis and treatment of psoriasis in childhood. These opinions are presented in the context of evidence from the literature and the current licensure status and indications of therapies for psoriasis in childhood. CONCLUSIONS: These data provide detailed information on the current practices in Europe for treating psoriasis in childhood.